We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+17%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.33B
AUM Growth
+$1.78B
(+24%)
Cap. Flow
+$552M
Cap. Flow
% of AUM
5.91%
Top 10 Holdings %
Top 10 Hldgs %
20.52%
Holding
814
New
78
Increased
378
Reduced
271
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.3M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$39.4M |
| 3 |
Intel
INTC
|
+$29.2M |
| 4 |
Qualcomm
QCOM
|
+$27.6M |
| 5 |
Danaher
DHR
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
+$49.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$41.6M |
| 3 |
ARQL
Arqule Inc
ARQL
|
+$26.5M |
| 4 |
Arrowhead Research
ARWR
|
+$24.9M |
| 5 |
Merck
MRK
|
+$15.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.73% |
| 2 | Technology | 19.55% |
| 3 | Financials | 10.18% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Communication Services | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Weyerhaeuser
WY
$17.3B
| $1.6M | 0.02% |
52,838
-13,709
| -21% | -$398K |
|
|
STML
577
DELISTED
Stemline Therapeutics, Inc.
STML
| $1.59M | 0.02% |
149,438
+35,438
| +31% | +$352K |
|
|
PBCT
578
DELISTED
People's United Financial Inc
PBCT
| $1.59M | 0.02% |
93,933
-1,936
| -2% | -$31.7K |
|
579
Dollar Tree
DLTR
$23.9B
| $1.56M | 0.02% |
16,631
-1,018
| -6% | -$107K |
|
580
Invesco
IVZ
$13.2B
| – | – |
-123,745
| Closed | -$2.11M |
|
581
Trip.com Group
TCOM
$28.2B
| $1.55M | 0.02% |
+46,100
| New | +$1.49M |
|
582
Lumen
LUMN
$6.34B
| $1.52M | 0.02% |
115,321
-40,955
| -26% | -$549K |
|
583
CoStar Group
CSGP
$12.1B
| $1.52M | 0.02% |
25,350
+2,860
| +13% | +$167K |
|
584
Albemarle
ALB
$13.6B
| $1.51M | 0.02% |
20,681
+12,186
| +143% | +$814K |
|
585
Amplify Cybersecurity ETF
HACK
$2.65B
| $1.5M | 0.02% |
36,105
-12,150
| -25% | -$486K |
|
|
XYZ
586
Block Inc
XYZ
$47.8B
| $1.5M | 0.02% |
24,011
-93
| -0.4% | -$5.94K |
|
587
Enbridge
ENB
$122B
| $1.49M | 0.02% |
37,432
-15,001
| -29% | -$560K |
|
588
Genuine Parts
GPC
$17.6B
| $1.49M | 0.02% |
14,021
-3,737
| -21% | -$384K |
|
589
American Airlines Group
AAL
$9.64B
| $1.48M | 0.02% |
51,752
-53,698
| -51% | -$1.53M |
|
590
DexCom
DXCM
$28.4B
| $1.48M | 0.02% |
27,032
+3,472
| +15% | +$165K |
|
|
DISCK
591
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $1.47M | 0.02% |
48,089
+4,161
| +9% | +$117K |
|
592
Arch Capital
ACGL
$36.4B
| $1.46M | 0.02% |
33,973
+3,205
| +10% | +$133K |
|
593
W.P. Carey
WPC
$17B
| $1.44M | 0.02% |
18,383
+4,197
| +30% | +$352K |
|
594
Codexis
CDXS
$139M
| $1.44M | 0.02% |
89,773
+62,329
| +227% | +$922K |
|
595
Markel Group
MKL
$25.2B
| $1.42M | 0.02% |
1,245
+133
| +12% | +$151K |
|
|
KSU
596
DELISTED
Kansas City Southern
KSU
| $1.38M | 0.01% |
8,975
+1,487
| +20% | +$218K |
|
597
STAAR Surgical
STAA
$1.15B
| $1.37M | 0.01% |
39,000
| – | – |
|
598
Invitation Homes
INVH
$17.6B
| $1.37M | 0.01% |
45,759
+11,092
| +32% | +$332K |
|
599
National Fuel Gas
NFG
$7.73B
| $1.36M | 0.01% |
29,157
+15,761
| +118% | +$719K |
|
600
Warner Bros
WBD
$63.6B
| $1.35M | 0.01% |
+41,136
| New | +$1.24M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2019 Portfolio in Review
As of Q4 2019, Candriam SCA held 814 positions worth $9.33B, up 24% from $7.55B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Candriam SCA deployed $552M of net new capital in Q4 2019, opening 78 new positions and adding to 378 existing holdings. Its largest new stake was Vipshop: 2,005,000 shares worth $28.4M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Ra Pharmaceuticals, Inc. Common Stock, an estimated $49.9M trimmed.
- Candriam SCA's largest Q4 2019 buy was Vipshop: 2,005,000 shares worth $28.4M.
- Candriam SCA added most to Microsoft in Q4 2019, an estimated $50.3M increase.
- Candriam SCA's biggest Q4 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $49.9M.
- Candriam SCA fully exited Hilton Worldwide in Q4 2019, selling an estimated $11.8M.
- Candriam SCA's ten largest holdings make up 21% of its $9.33B portfolio in Q4 2019.
- Candriam SCA opened 78 new positions and closed 33 in Q4 2019.
- Candriam SCA's portfolio value rose 24% quarter-over-quarter to $9.33B.
Based on Candriam SCA's 13F filing for Q4 2019, filed 21 Jan 2020.